United States : U.S. FDA Approves INREBIC (Fedratinib) as First New Treatment in Nearly a Decade for Patients With Myelofibrosis

Press/Media: Press / Media

PeriodAug 24 2019

Media coverage

1

Media coverage

  • TitleUnited States : U.S. FDA Approves INREBIC (Fedratinib) as First New Treatment in Nearly a Decade for Patients With Myelofibrosis
    Media name/outletTendersInfo – News
    CountryIndia
    Date8/24/19
    PersonsRuben Mesa
View all 1
View less